Bausch & Lomb Corp

TSX:BLCO (Canada)  
C$ 28.65 (+3.17%) Nov 27
At Loss
P/B:
1.13
Market Cap:
C$ 10.09B ($ 7.19B)
Enterprise V:
C$ 16.13B ($ 11.50B)
Volume:
1.83K
Avg Vol (2M):
2.11K
Trade In:
Volume:
1.83K
At Loss
Avg Vol (2M):
2.11K

Business Description

Description
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Name Current Vs Industry Vs History
Cash-To-Debt 0.07
Equity-to-Asset 0.49
Debt-to-Equity 0.7
Debt-to-EBITDA 8.19
Interest Coverage 0.43
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.04
Distress
Grey
Safe
Beneish M-Score -2.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 70.57
9-Day RSI 62.05
14-Day RSI 58.99
6-1 Month Momentum % 40.74
12-1 Month Momentum % 36.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.57
Quick Ratio 0.95
Cash Ratio 0.18
Days Inventory 200.89
Days Sales Outstanding 69.68
Days Payable 86.47

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1
Shareholder Yield % -22.07

Financials (Next Earnings Date:2025-02-21 Est.)

TSX:BLCO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bausch & Lomb Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 6,347.933
EPS (TTM) (C$) -1.426
Beta 0
Volatility % 44.12
14-Day RSI 58.99
14-Day ATR (C$) 0.690778
20-Day SMA (C$) 27.70925
12-1 Month Momentum % 36.22
52-Week Range (C$) 18.11 - 29.37
Shares Outstanding (Mil) 352.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bausch & Lomb Corp Filings

Filing Date Document Date Form
No Filing Data

Bausch & Lomb Corp Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Bausch & Lomb Corp Frequently Asked Questions

What is Bausch & Lomb Corp(TSX:BLCO)'s stock price today?
The current price of TSX:BLCO is C$28.65. The 52 week high of TSX:BLCO is C$29.37 and 52 week low is C$18.11.
When is next earnings date of Bausch & Lomb Corp(TSX:BLCO)?
The next earnings date of Bausch & Lomb Corp(TSX:BLCO) is 2025-02-21 Est..
Does Bausch & Lomb Corp(TSX:BLCO) pay dividends? If so, how much?
Bausch & Lomb Corp(TSX:BLCO) does not pay dividend.

Press Release

Subject Date
No Press Release